Sign in
4

Changes in Ownership

IRulya Therapeutics Inc. Filed Acc 0001209191-23-045432

Chief Executive Officer bought 88,000 shares at $1.26 ($110,880)

From the SEC's structured data for this filing

Trades in this filing

Thye Dirk · Chief Executive Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2023-08-10 Purchase : show line 1 in the form +88,000 $1.26 $110,880 448,911 D
Open-market purchases · 88,000 sh · avg $1.26 · $110,880
Loading xslF345X05/doc4.xml…